With Arnie Mandel Robert Preidt Health Day Reporter
Thursday, February 18, 2021 (HealthDay News)-Diabetes is a major risk factor for severe attacks of COVID-19, a new European study confirms it: in five hospitalized COVID-19 patients One person with diabetes dies within 28 days of admission.
One US expert wasn’t surprised by the harsh findings.
“Diabetics are clearly in a very high-risk category and will be one of the first groups to get the vaccine,” said Dr. Mangalana Rasimhan, who directs critical care services at Northwell Health in New Hyde Park, NY. It should be. ” People with diabetes control their blood sugar levels and make sure they avoid complications of the disease.
Such steps “seem to really make a difference in terms of survival from COVID infection,” said Narasimhan, who was not involved in the new study.
The study was led by Bertrand Kariu and Sammy Hajaji, diabetes specialists at Nantes University Hospital in France. In May last year, they released preliminary findings showing that 10% of COVID-19 diabetics died within 7 days of admission.
The latest and most recent results are from a large number of patients (nearly 2,800) treated for COVID-19 in 68 hospitals across France. Their average age was 70, nearly two-thirds were male, and many were overweight. About 40% also experienced various forms of complications from diabetes.
The French team reported in a journal on February 17 that 21% of patients died 28 days after admission. Diabetology..
Of the patients who survived at least 1 month, 50% were discharged with a median stay of 9 days. 12% were still hospitalized on day 28 and 17% were transferred from the first hospital to another facility.
Researchers said routine treatment for diabetes at a young age with a drug called metformin and long pre-hospital symptoms were important factors associated with a high likelihood of discharge.
Patients who took insulin regularly (probably showing more advanced diabetes) had a 44% higher risk of death than those who did not take insulin, the researchers said. Long-term glycemic control was not associated with patient outcomes, but strongly predicted that higher glycemic levels at admission were less likely to result in death and discharge.
Dr. Barbara Keber directs family medicine at Glen Cove Hospital in Glen Cove, NY. Reading the findings, she said, “Diabetes is clearly an important risk factor for both the need for ICU / ventilator care in the hospital and death.” Within one month of admission.
Keber says it “reasons” that people with uncontrolled diabetic complications are at higher risk because they create an “inflammatory condition” similar to that found in advanced COVID-19. Said.
However, Keber also warned that mortality in COVID-19 patients, including diabetics, may have improved over the past year.
“This study was conducted in the first wave of the pandemic and found that many of the current treatment regimens and medications attempted in the early stages were not beneficial and replaced other treatment regimens,” she said. It was.
For example, “The current use of steroids for treatment is [improved] The prognosis for all patients, especially for diabetics. “
More about the American Diabetes Association COVID-19 (new coronavirus infection) (# If there is no character limit, add parentheses when it first appears..
Source: Mangala Narasimhan, DO, Director, Critical Care Services, Northwell Health, New Hyde Park, NY. Barbara Keber, MD, Chair, Family Medicine, Glen Cove Hospital, Glen Cove, New York; Diabetology, News Release, February 17, 2021
Copyright © 2021 HealthDay.. all rights reserved.
What Are The Main Benefits Of Comparing Car Insurance Quotes Online
to request, modification Contact us at Here or [email protected]